HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Massimo Valoti Selected Research

Leukemia L5178

3/2016Interactions of human P-glycoprotein transport substrates and inhibitors at the drug binding domain: Functional and molecular docking analyses.
12/2011N,N-bis(cyclohexanol)amine aryl esters inhibit P-glycoprotein as transport substrates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Massimo Valoti Research Topics

Disease

6Neoplasms (Cancer)
05/2022 - 04/2006
6Neuroblastoma
03/2022 - 02/2016
4Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021 - 06/2008
4Parkinson Disease (Parkinson's Disease)
01/2016 - 09/2003
3Reperfusion Injury
12/2012 - 01/2007
3Ischemia
12/2012 - 04/2007
2Epilepsy (Aura)
01/2021 - 05/2006
2Glioblastoma (Glioblastoma Multiforme)
06/2019 - 01/2017
2Leukemia L5178
03/2016 - 12/2011
2Hypothermia
01/2004 - 06/2003
1Carcinoma (Carcinomatosis)
05/2022
1Squamous Cell Carcinoma of Head and Neck
05/2022
1Starvation
05/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2022
1Obesity
01/2022
1Inflammation (Inflammations)
12/2021
1Torsades de Pointes (Torsade de Pointes)
05/2021
1Ventricular Tachycardia
05/2021
1Hepatocellular Carcinoma (Hepatoma)
05/2021
1Hemolysis
05/2021
1Seizures (Absence Seizure)
01/2021
1Idiopathic Pulmonary Fibrosis
01/2021
1Temporal Lobe Epilepsy
01/2021
1Status Epilepticus (Complex Partial Status Epilepticus)
01/2021
1Mitochondrial Diseases (Mitochondrial Disease)
05/2020
1Melanoma (Melanoma, Malignant)
01/2018
1Basal Cell Carcinoma (Rodent Ulcer)
01/2018
1Craniocerebral Trauma (Head Injury)
01/2016
1Overactive Urinary Bladder (Overactive Bladder)
12/2012
1Contracture
01/2012
1Leukemia
04/2011
1Brain Diseases (Brain Disorder)
01/2010
1Stroke (Strokes)
10/2009
1Brain Edema (Cerebral Edema)
10/2009

Drug/Important Bio-Agent (IBA)

4Pharmaceutical PreparationsIBA
01/2022 - 01/2018
4PyrimidinesIBA
06/2019 - 04/2011
4Member 1 Subfamily B ATP Binding Cassette TransporterIBA
06/2019 - 12/2011
3Biological ProductsIBA
01/2021 - 01/2010
3Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
05/2020 - 09/2003
3TaurineFDA Link
10/2009 - 06/2003
2Antineoplastic Agents (Antineoplastics)IBA
03/2022 - 01/2017
2pyrimidineIBA
03/2022 - 06/2019
2Reactive Oxygen Species (Oxygen Radicals)IBA
12/2021 - 05/2021
2Ethanol (Ethyl Alcohol)IBA
05/2020 - 10/2018
2ProdrugsIBA
06/2019 - 01/2017
2Liposomes (Liposome)IBA
01/2018 - 02/2016
2EstersIBA
03/2016 - 12/2011
2Rhodamine 123IBA
03/2016 - 12/2011
2Monoamine Oxidase (MAO)IBA
01/2016 - 06/2008
2gamma-Aminobutyric Acid (GABA)IBA
06/2012 - 05/2006
2N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamineIBA
01/2010 - 06/2008
1Proteins (Proteins, Gene)FDA Link
05/2022
1TubulinIBA
05/2022
1CSK Tyrosine-Protein KinaseIBA
03/2022
1FlavonoidsIBA
01/2022
1GemcitabineFDA Link
01/2022
1Nonesterified Fatty Acids (NEFA)IBA
01/2022
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
12/2021
1Ether (Diethyl Ether)IBA
05/2021
1Drug CarriersIBA
05/2021
1MCM-41IBA
05/2021
1EndocannabinoidsIBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2021
1Pilocarpine (Ocusert)FDA LinkGeneric
01/2021
1NF-kappa B (NF-kB)IBA
01/2021
1NeurotoxinsIBA
05/2020
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
05/2020
1Protein Isoforms (Isoforms)IBA
05/2020
1Adenosine Triphosphate (ATP)IBA
06/2019
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
06/2019
1src-Family KinasesIBA
06/2019
1IsoenzymesIBA
10/2018
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2018
1FluoridesIBA
01/2018
1HhAntag691IBA
01/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018
1AlbuminsIBA
02/2016
1LigandsIBA
01/2016
1SMe1EC2IBA
01/2016
1N- ((5- (3- (1- benzylpiperidin- 4- yl)propoxy)- 1- methyl- 1H- indol- 2- yl)methyl)- N- methylprop- 2- yn- 1- amineIBA
01/2016
1Oxidoreductases (Dehydrogenase)IBA
01/2016
1dicarbineIBA
01/2016
1Cholinesterases (Cholinesterase)IBA
01/2016
1N- (adamantan- 1- yl)- 4- oxo- 1- pentyl- 6- phenyl- 1,4- dihydroquinoline- 3- carboxamideIBA
12/2012
1CB2 Cannabinoid ReceptorIBA
12/2012
1hypericinIBA
12/2012
1hyperforinIBA
12/2012
14-quinolone-3-carboxylic acidIBA
12/2012
14-Aminobutyrate Transaminase (4 Aminobutyrate Transaminase)IBA
06/2012
1SolutionsIBA
01/2012
1AminesIBA
12/2011
1CyclohexanolsIBA
12/2011
1Adenosine Triphosphatases (ATPase)IBA
12/2011
1ThioureaIBA
01/2010
1Neuroprotective AgentsIBA
01/2010
1Guanidine (Guanidine Nitrate)FDA Link
01/2010
1RiluzoleFDA LinkGeneric
01/2010
11-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA
06/2008

Therapy/Procedure

2Therapeutics
05/2022 - 06/2019